Literature DB >> 17667605

Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.

Francesc Cobo1, Guillem De Celis, Arturo Pereira, Xavier Latorre, Jaume Pujadas, Santiago Albiol.   

Abstract

We report a 59-year-old woman diagnosed with metastasic colorectal cancer who developed immune hemolytic anemia during FOLFOX chemotherapy (oxaliplatin/leucovorin/5-fluorouracil). Immunohematologic studies demonstrated that immune hemolysis was oxaliplatin-mediated. On the basis of this case and in a review of the literature in which 13 cases of previously reported oxaliplatin-induced immune cytopenia have been identified, we suggest some clinical clues regarding the use of oxaliplatin in cancer patients.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17667605     DOI： 10.1097/CAD.0b013e3280e9496d

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN： 0959-4973            Impact factor:   2.248


  10 in total

Review 1.  Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Authors:  Marnelli A Bautista; W Tait Stevens; Chien-Shing Chen; Brian R Curtis; Richard H Aster; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2010-03-26       Impact factor: 17.388

2.  Acute renal failure related to oxaliplatin-induced intravascular hemolysis.

Authors:  Ayhan Ulusakarya; Srimanta Misra; Mazen Haydar; Hélène Habert; Vincent Castagne; Yusuf Gumus; Béatrice Delmas-Marsalet; David Machover
Journal:  Med Oncol       Date:  2009-06-30       Impact factor: 3.064

3.  Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.

Authors:  Yunfu Lv; Wan Yee Lau; Hongfei Wu; XiaoYu Han; Xiaoguang Gong; Ning Liu; Jie Yue; Qingqing Li; YeJuan Li; Jie Deng
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 4.  Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review.

Authors:  Jiun-I Lai; Wei-Shu Wang
Journal:  Pharm World Sci       Date:  2009-07-09

5.  New in vitro highly cytotoxic platinum and palladium cyanoximates with minimal side effects in vivo.

Authors:  Stephanie D Dannen; Lauren Cornelison; Paul Durham; John E Morley; Kiana Shahverdi; Junwei Du; Haiying Zhou; Leland C Sudlow; Daniel Hunter; Matthew D Wood; Mikhail Y Berezin; Nikolay Gerasimchuk
Journal:  J Inorg Biochem       Date:  2020-05-06       Impact factor: 4.155

6.  Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor.

Authors:  Kristina M Haley; Thomas B Russell; Lynn Boshkov; Regina M Leger; George Garratty; Michael Recht; Kellie J Nazemi
Journal:  J Blood Med       Date:  2014-05-15

7.  Severe acute tubular necrosis observed subsequent to oxaliplatin administration.

Authors:  Niall Filewod; Mark L Lipman
Journal:  Clin Kidney J       Date:  2013-12-29

8.  Carboplatin Induced Fatal Autoimmune Hemolytic Anemia: First Reported Case.

Authors:  Sunil Dacha; Anil K Reddivari; Shadi Latta; Manjari Devidi; Nkemakolam Iroegbu
Journal:  World J Oncol       Date:  2010-08-29

9.  Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension.

Authors:  Yunfu Lv; Hongfei Wu; Wan Yee Lau; Jinfang Zheng; Jincai Wu; Min Zeng
Journal:  Sci Rep       Date:  2021-10-28       Impact factor: 4.379

10.  Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy.

Authors:  Eric L Tam; Padma L Draksharam; Jennifer A Park; Gurinder S Sidhu
Journal:  Case Rep Oncol Med       Date:  2019-11-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.